“Evaluation of Response to Ritlecitinib Treatment Based on SALT Improvement Scores in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s187. doi:10.25251/skin.7.supp.187.